Patients with both sarcopenia and high IL-16 expression had significantly poorer OS (HR, 2.43; 95% CI, 1.47–4.69) and RFS (HR, 3.02; 95% CI, 1.64–5.91) than those without any of the above two risk factors. This evidence concerns the gene IL16 and sarcopenia.